Evaluation of 177Lu-CHX-A''-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers

Simple item page
dc.contributor.authorKameswaran, M.
dc.contributor.authorPandey, U.
dc.contributor.authorGamre, N.
dc.contributor.authorVimalnath, K. V.
dc.contributor.authorSarma, H. D.
dc.contributor.authorDash, A.
dc.date.accessioned2017-03-06T06:29:23Z
dc.date.available2017-03-06T06:29:23Z
dc.date.issued2016
dc.description.divisionIP&AD;RB&HSDen
dc.format.extent4061 bytes
dc.format.mimetypetext/html
dc.identifier.sourceApplied Radiation and Isotopes, 2016. Vol. 114: pp. 196-201en
dc.identifier.urihttp://hdl.handle.net/123456789/14126
dc.language.isoenen
dc.subjectVascular Endothelial Growth Factor(VEGF)en
dc.subjectBevacizumaben
dc.subject177Lu-CHX-A"-DTPA-Bevacizumaben
dc.subjectMelanomaen
dc.titleEvaluation of 177Lu-CHX-A''-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancersen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0816.htm
Size:
3.97 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2016